James Schmidt: 4,209 shares sold after option exercise

The filing reports a Rule 144 sale related entry: 4,209 shares of Common Stock were sold on 06/22/2026 following an exercise of stock options with the counterparty listed as the Issuer and payment by cash.

Rhea-AI Filing Summary

The filing reports a Rule 144 sale related entry: 4,209 shares of Common Stock were sold on 06/22/2026 following an exercise of stock options with the counterparty listed as the Issuer and payment by cash. The filing also lists prior 10b5-1 sales by James Schmidt: 5,000 shares on 06/01/2026 for $1,609,125.50, 4,274 shares on 05/04/2026 for $1,080,961.27, and 1,241 shares on 04/27/2026 for $343,757.00.

Insights

Securities Compliance Analyst

Routine Rule 144 / 10b5-1 transactions; no new corporate guidance.

The excerpt lists a 4,209-share disposition dated 06/22/2026 described as an exercise of stock options with the purchaser labeled as the Issuer and payment by cash. It also records three prior 10b5-1 sales by James Schmidt totaling 10,515 shares across April–June 2026.

These entries are administrative transfer/sale events; cash‑flow treatment and any tax withholding mechanics are limited to the listed labels. Subsequent filings or footnotes would be needed for additional ownership or timing context.

Key Figures

Shares sold (exercise): 4,209 shares 10b5-1 sale on 06/01/2026: 5,000 shares Proceeds 06/01/2026: $1,609,125.50 +4 more

7 metrics

Shares sold (exercise) 4,209 shares sale following option exercise on <date>06/22/2026

10b5-1 sale on 06/01/2026 5,000 shares 10b5-1 sale by James Schmidt on <date>06/01/2026

Proceeds 06/01/2026 $1,609,125.50 proceeds reported for 5,000-share 10b5-1 sale

10b5-1 sale on 05/04/2026 4,274 shares 10b5-1 sale by James Schmidt on <date>05/04/2026

Proceeds 05/04/2026 $1,080,961.27 proceeds reported for 4,274-share 10b5-1 sale

10b5-1 sale on 04/27/2026 1,241 shares 10b5-1 sale by James Schmidt on <date>04/27/2026

Proceeds 04/27/2026 $343,757.00 proceeds reported for 1,241-share 10b5-1 sale

Key Terms

Rule 144, 10b5-1 Sales, Exercise of Stock Options, Issuer

4 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for JAMES SCHMIDT"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | Cash"

Issuer other

"Issu er listed as purchaser in the sale line"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for VICR disclose about the 06/22/2026 transaction?

The Form 144 shows 4,209 shares sold on 06/22/2026 after an exercise of stock options, with the purchaser listed as the Issuer and payment in cash. The filing does not provide further detail on price per share.

Who executed prior 10b5-1 sales disclosed in this filing for VICR?

James Schmidt executed prior 10b5-1 sales: 1,241 shares on 04/27/2026, 4,274 shares on 05/04/2026, and 5,000 shares on 06/01/2026, with proceeds shown for each sale in the excerpt.

How much cash did the 10b5-1 sales generate as shown in the excerpt?

The excerpt lists proceeds of $343,757.00 for 04/27/2026, $1,080,961.27 for 05/04/2026, and $1,609,125.50 for 06/01/2026, tied to the respective 10b5-1 sales by James Schmidt.

Does the filing state whether the 4,209-share sale was a cashless exercise or a cash exercise?

The filing labels the 06/22/2026 event as an exercise of stock options with payment type shown as Cash, indicating a cash exercise per the excerpt rather than a cashless swap.

Are the prior 10b5-1 sales in the excerpt disclosed as planned or discretionary?

The excerpt identifies those transactions as 10b5-1 Sales, which indicates they were effected under a prearranged trading plan per the filing language shown; no additional footnote details are provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:41 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001866281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VICOR CORPORATION
SEC File Number	000-18277
Address of Issuer	25 Frontage Road Andover MASSACHUSETTS 01810
Phone	9784702900
Name of Person for Whose Account the Securities are To Be Sold	JAMES SCHMIDT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4209	1394736.33	33863689	06/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/22/2026	Exercise of Stock Options	Issuer			4209	06/22/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES SCHMIDT 25 Frontage Road Andover MA 01810	Common	06/01/2026	5000	1609125.50
10b5-1 Sales for JAMES SCHMIDT 25 Frontage Road Andover MA 01810	Common	05/04/2026	4274	1080961.27
10b5-1 Sales for JAMES SCHMIDT 25 Frontage Road Andover MA 01810	Common	04/27/2026	1241	343757.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	06/22/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Schmidt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)